rs150887575

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_000483.5(APOC2):​c.34G>A​(p.Val12Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000295 in 1,614,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V12V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00026 ( 1 hom. )

Consequence

APOC2
NM_000483.5 missense

Scores

17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.914

Publications

6 publications found
Variant links:
Genes affected
APOC2 (HGNC:609): (apolipoprotein C2) This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is secreted in plasma where it is a component of very low density lipoprotein. This protein activates the enzyme lipoprotein lipase, which hydrolyzes triglycerides and thus provides free fatty acids for cells. Mutations in this gene cause hyperlipoproteinemia type IB, characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis. This gene is present in a cluster with other related apolipoprotein genes on chromosome 19. Naturally occurring read-through transcription exists between this gene and the neighboring upstream apolipoprotein C-IV (APOC4) gene. [provided by RefSeq, Mar 2011]
APOC4-APOC2 (HGNC:44426): (APOC4-APOC2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring apolipoprotein C-IV (APOC4) and apolipoprotein C-II (APOC2) genes on chromosome 19. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0075594783).
BP6
Variant 19-44948512-G-A is Benign according to our data. Variant chr19-44948512-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1530932.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000584 (89/152274) while in subpopulation AMR AF = 0.000981 (15/15294). AF 95% confidence interval is 0.000664. There are 0 homozygotes in GnomAd4. There are 51 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000483.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOC2
NM_000483.5
MANE Select
c.34G>Ap.Val12Ile
missense
Exon 2 of 4NP_000474.2
APOC4-APOC2
NR_037932.1
n.1241G>A
non_coding_transcript_exon
Exon 4 of 6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOC2
ENST00000252490.7
TSL:2 MANE Select
c.34G>Ap.Val12Ile
missense
Exon 2 of 4ENSP00000252490.5P02655
APOC4-APOC2
ENST00000589057.5
TSL:5
c.265G>Ap.Val89Ile
missense
Exon 3 of 5ENSP00000468139.1K7ER74
APOC2
ENST00000896555.1
c.34G>Ap.Val12Ile
missense
Exon 2 of 4ENSP00000566614.1

Frequencies

GnomAD3 genomes
AF:
0.000585
AC:
89
AN:
152156
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000346
AC:
87
AN:
251484
AF XY:
0.000361
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.00347
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000265
AC:
387
AN:
1461856
Hom.:
1
Cov.:
32
AF XY:
0.000254
AC XY:
185
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000926
AC:
31
AN:
33480
American (AMR)
AF:
0.000626
AC:
28
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00383
AC:
100
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53414
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.000170
AC:
189
AN:
1111988
Other (OTH)
AF:
0.000497
AC:
30
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000584
AC:
89
AN:
152274
Hom.:
0
Cov.:
31
AF XY:
0.000685
AC XY:
51
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41568
American (AMR)
AF:
0.000981
AC:
15
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68016
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000548
Hom.:
1
Bravo
AF:
0.000669
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000313
AC:
38
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
0.056
DANN
Benign
0.73
DEOGEN2
Benign
0.013
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
0.64
N
PhyloP100
-0.91
PROVEAN
Benign
-0.50
N
REVEL
Benign
0.090
Sift
Benign
0.40
T
Sift4G
Benign
0.33
T
Polyphen
0.0090
B
Vest4
0.088
MVP
0.16
MPC
0.15
ClinPred
0.0056
T
GERP RS
-2.0
PromoterAI
-0.012
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.023
gMVP
0.33
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150887575; hg19: chr19-45451769; COSMIC: COSV106088214; COSMIC: COSV106088214; API